Concepedia

U. Mueller

UM

12

Publications

309

Citations

11

H-Index

1995

Active since

Affiliations

Bayer (United States)(Current)

Bayer (Germany)

Teva Pharmaceuticals (Germany)

Institut Gustave Roussy

Université Paris-Saclay

U. Mueller is an author at Bayer (United States) specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1995–2024

12

Publications

12

Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study

Marwan Fakih, Kanwal Pratap Singh Raghav, David Chang et al. · EClinicalMedicine · 2023 · 92 citations · Full text

Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies

Birgit Geoerger, Bruce Morland, Irène Jiménez et al. · European Journal of Cancer · 2021 · 30 citations · Full text

Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study

Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson et al. · Clinical Cancer Research · 2023 · 29 citations · Full text

Diuretic-related hypokalaemia: the role of diuretics, potassium supplements, glucocorticoids and ?2-adrenoceptor agonists

P. Widmer, Roman Capaul, U. Mueller et al. · European Journal of Clinical Pharmacology · 1995 · 25 citations

, , +12

Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients With Arsenic Trioxide and Retinoic Acid in the United States

Martin S. Tallman, Francesco Lo‐Coco, Gisoo Barnes et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 23 citations · Full text

, , +13

Rows per page

1–5 of 12